163 related articles for article (PubMed ID: 32094096)
21. Effect of Genetic Polymorphism of CYP3A5 and CYP2C19 and Concomitant Use of Voriconazole on Blood Tacrolimus Concentration in Patients Receiving Hematopoietic Stem Cell Transplantation.
Iwamoto T; Monma F; Fujieda A; Nakatani K; Gayle AA; Nobori T; Katayama N; Okuda M
Ther Drug Monit; 2015 Oct; 37(5):581-8. PubMed ID: 25565672
[TBL] [Abstract][Full Text] [Related]
22. Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patients.
Xue L; Zhang WW; Ding XL; Zhang JJ; Bao JA; Miao LY
Am J Med Sci; 2014 Dec; 348(6):448-54. PubMed ID: 25247760
[TBL] [Abstract][Full Text] [Related]
23. A drug transporter for all ages? ABCB1 and the developmental pharmacogenetics of cyclosporine.
Hesselink DA; van Schaik RH; Nauta J; van Gelder T
Pharmacogenomics; 2008 Jun; 9(6):783-9. PubMed ID: 18518855
[TBL] [Abstract][Full Text] [Related]
24. Hepatic drug interaction between tacrolimus and lansoprazole in a bone marrow transplant patient receiving voriconazole and harboring CYP2C19 and CYP3A5 heterozygous mutations.
Iwamoto T; Monma F; Fujieda A; Nakatani K; Katayama N; Okuda M
Clin Ther; 2011 Aug; 33(8):1077-80. PubMed ID: 21802143
[TBL] [Abstract][Full Text] [Related]
25. [Drug interaction of voriconazole-cyclosporine in children undergoing hematopoietic stem cell transplantation (2013-2014)].
Valenzuela R; Torres JP; Salas C; Gajardo I; Palma J; Catalán P; Santolaya ME; Morales J
Rev Chilena Infectol; 2017 Feb; 34(1):14-18. PubMed ID: 28394976
[TBL] [Abstract][Full Text] [Related]
26. Drug interactions between micafungin at high doses and cyclosporine A in febrile neutropenia patients after allogeneic hematopoietic stem cell transplantation.
Inoue Y; Saito T; Ogawa K; Nishio Y; Kosugi S; Suzuki Y; Kato M; Sakai T; Takahashi M; Miura I
Int J Clin Pharmacol Ther; 2012 Nov; 50(11):831-7. PubMed ID: 22943928
[TBL] [Abstract][Full Text] [Related]
27. Population pharmacokinetics of cyclosporine in hematopoietic stem cell transplant patients: consideration of genetic polymorphisms.
Kim MG; Kim IW; Choi B; Han N; Yun HY; Park S; Oh JM
Ann Pharmacother; 2015 Jun; 49(6):622-30. PubMed ID: 25818517
[TBL] [Abstract][Full Text] [Related]
28. Effect of CYP3A5 and ABCB1 Gene Polymorphisms on Tacrolimus Blood Concentration in Renal Transplant Recipients.
Yildirim E; Şahin G; Kaltuş Z; Çolak E
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710427
[TBL] [Abstract][Full Text] [Related]
29. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.
Staatz CE; Goodman LK; Tett SE
Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406
[TBL] [Abstract][Full Text] [Related]
30. The new CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with an increased risk of delayed graft function and worse renal function in cyclosporine-treated kidney transplant patients.
Elens L; Bouamar R; Hesselink DA; Haufroid V; van Gelder T; van Schaik RH
Pharmacogenet Genomics; 2012 May; 22(5):373-80. PubMed ID: 22388796
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients.
Santoro A; Felipe CR; Tedesco-Silva H; Medina-Pestana JO; Struchiner CJ; Ojopi EB; Suarez-Kurtz G
Pharmacogenomics; 2011 Sep; 12(9):1293-303. PubMed ID: 21806386
[TBL] [Abstract][Full Text] [Related]
32. Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients.
Zhu J; Patel T; Miller JA; Torrice CD; Aggarwal M; Sketch MR; Alexander MD; Armistead PM; Coghill JM; Grgic T; Jamieson KJ; Ptachcinski JR; Riches ML; Serody JS; Schmitz JL; Shaw JR; Shea TC; Suzuki O; Vincent BG; Wood WA; Rao KV; Wiltshire T; Weimer ET; Crona DJ
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013193
[TBL] [Abstract][Full Text] [Related]
33. Association of polymorphism of
Wang L; Zeng G; Li J; Luo J; Li H; Zhang Z
Xenobiotica; 2021 Jul; 51(7):852-858. PubMed ID: 33974505
[TBL] [Abstract][Full Text] [Related]
34. Genotype-Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation.
Teusink A; Vinks A; Zhang K; Davies S; Fukuda T; Lane A; Nortman S; Kissell D; Dell S; Filipovich A; Mehta P
Biol Blood Marrow Transplant; 2016 Mar; 22(3):482-6. PubMed ID: 26616742
[TBL] [Abstract][Full Text] [Related]
35. [Pharmacogenetic analysis of the absorption kinetics of cyclosporine in a population of Spanish cardiac transplant patients].
Isla Tejera B; Aumente Rubio MD; Martínez-Moreno J; Reyes Malia M; Arizón JM; Suárez García A
Farm Hosp; 2009; 33(6):324-9. PubMed ID: 20038391
[TBL] [Abstract][Full Text] [Related]
36. Drug interaction between letermovir and voriconazole after allogeneic hematopoietic cell transplantation.
Nakashima T; Inamoto Y; Fukushi Y; Doke Y; Hashimoto H; Fukuda T; Yamaguchi M
Int J Hematol; 2021 Jun; 113(6):872-876. PubMed ID: 33677768
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenetic study of ABCB1 and CYP3A5 genes during the first year following heart transplantation regarding tacrolimus or cyclosporine levels.
Jordán de Luna C; Herrero Cervera MJ; Sánchez Lázaro I; Almenar Bonet L; Poveda Andrés JL; Aliño Pellicer SF
Transplant Proc; 2011; 43(6):2241-3. PubMed ID: 21839244
[TBL] [Abstract][Full Text] [Related]
38. Variability of voriconazole plasma concentrations after allogeneic hematopoietic stem cell transplantation: impact of cytochrome p450 polymorphisms and comedications on initial and subsequent trough levels.
Gautier-Veyret E; Fonrose X; Tonini J; Thiebaut-Bertrand A; Bartoli M; Quesada JL; Bulabois CE; Cahn JY; Stanke-Labesque F
Antimicrob Agents Chemother; 2015 Apr; 59(4):2305-14. PubMed ID: 25645831
[TBL] [Abstract][Full Text] [Related]
39. Drug interaction between voriconazole and tacrolimus and its association with the bioavailability of oral voriconazole in recipients of allogeneic hematopoietic stem cell transplantation.
Mori T; Kato J; Yamane A; Sakurai M; Kohashi S; Kikuchi T; Ono Y; Okamoto S
Int J Hematol; 2012 May; 95(5):564-9. PubMed ID: 22461034
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of a Once-Daily Dose of Tacrolimus Early After Liver Transplantation: With Special Reference to CYP3A5 and ABCB1 Single Nucleotide Polymorphisms.
Miyata Y; Akamatsu N; Sugawara Y; Kaneko J; Yamamoto T; Suzuki H; Arita J; Sakamoto Y; Hasegawa K; Tamura S; Kokudo N
Ann Transplant; 2016 Aug; 21():491-9. PubMed ID: 27503662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
